
Cstone Presents Preclinical Results Of CS2011 (EGFR/HER3 Bispecific Antibody), CS5007 (EGFR/HER3 Bispecific ADC), CS5005 ...
(MENAFN- PR Newswire) SUZHOU, China, May 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of …